TABLE 6.
Results for 25 sera that were ASCA negative/OmpC positive as determined by Prometheus Laboratories
| Sample no. | Result
|
|||||
|---|---|---|---|---|---|---|
| Prometheus OmpC IgA (EU/ml)a | INOVA OMP IgAb | ARUP ASCA IgA | ARUP ASCA IgG | ARUP pANCA IgG | Prometheus pANCA IgGc | |
| 6 | 20.0 | EQV | − | − | + | + (S) |
| 16 | 19.7 | − | − | − | − | − |
| 24 | 18.0 | EQV | − | − | − | − |
| 49 | 37.7 | + | − | + | − | − |
| 55 | 20.4 | EQV | − | − | − | + (R) |
| 69 | 27.9 | + | − | − | + | + (S) |
| 79 | 26.3 | + | − | − | + | + (S) |
| 80 | 21.3 | − | − | − | − | − |
| 82 | 20.2 | − | − | − | + | + (S) |
| 89 | 16.8 | − | − | − | − | − |
| 93 | 40.2 | + | − | − | − | + (S) |
| 102 | 22.8 | − | − | − | − | − |
| 107 | 25.9 | − | − | − | + | + (S) |
| 108 | 41.4 | + | − | − | + | + (S) |
| 111 | 18.1 | − | − | − | − | − |
| 116 | 16.9 | EQV | − | − | − | + (R) |
| 133 | >111.0 | + | + | + | − | + (S) |
| 135 | 20.6 | − | + | − | + | + (S) |
| 137 | 23.2 | EQV | − | − | + | + (S) |
| 150 | 19.3 | − | − | − | − | − |
| 152 | 20.1 | − | − | − | + | + (S) |
| 153 | 18.6 | + | − | − | + | − |
| 166 | 54.0 | + | − | − | − | − |
| 188 | 60.6 | + | − | − | − | + (S) |
| 205 | 17.0 | QNS | − | − | − | − |
a
16.5 EU/ml or greater is considered positive.
b
EQV, equivocal; QNS, quantity not sufficient.
c
(S), DNase sensitive; (R), DNase resistant.